Chee Kong Choo - 20 Feb 2025 SCHEDULE 13D/A Report for CytoMed Therapeutics Ltd Ordinary Shares (GDTC)

Filing Manager: Chee Kong Choo
Reporting Manager: Choo Chee Kong
Security: CytoMed Therapeutics Ltd Ordinary Shares
Symbol: GDTC
Shares outstanding: 11,537,872 shares
Disclosed Ownership: 2,673,325 shares
Ownership: 23%
Form type: SCHEDULE 13D/A
Filing time: 14 Mar 2025, 19:09:41 UTC
Date of event: 20 Feb 2025
Next filing: 29 Oct 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Choo Chee Kong	23%	2,673,325	598,015	3,773,291	/s/ Choo Chee Kong	Choo Chee Kong / Chairman and Director of CytoMed Therapeutics Limited	0001970632